Financing for Linden’s Acquisition of Avalign Technologies
January 3, 2019
On December 21st, KeyBanc Capital Markets Inc. (“KBCM”) successfully closed the syndication of $325.0 million of senior secured credit facilities for Avalign Technologies, Inc. (“Avalign” or the “Company”). The facilities are comprised of a $35.0 million Revolving Credit Facility (the “Revolver”) and a $200.0 million First Lien Term Loan (the “First Lien Term Loan”), and a privately placed $90.0 million Second Lien Term Loan (the “Second Lien Term Loan”). Proceeds from the facilities were used to support Linden Capital Partners’ (“Linden” or the “Sponsor”) acquisition of Avalign. KBCM served as Left Lead Arranger, Joint Bookrunner & Administrative Agent on the First Lien Credit Facilities. KBCM was chosen to lead the financing transaction due to its strong relationship with the Company and Sponsor, and its Healthcare Industry and Leveraged Finance expertise.
About Avalign Technologies, Inc.:
Founded in 2007, Avalign is a premier medical device outsourcing partner and leading provider of proprietary coatings and precision manufacturing solutions for medical device OEMs. The Company develops, manufactures, and supplies implants, instruments, cutting tools, specialty surgical instruments, and metal and thermoformed cases and trays to its diversified customer base. Avalign is based in Bannockburn, Illinois and has facilities in the United States and Europe.
About Linden Capital Partners:
Linden Capital Partners is a Chicago-based private equity firm that manages approximately $3.0 billion, and is focused exclusively on the healthcare sector. The firm targets investments that are principally located in North America and are focused on the services, medical products, pharmaceutical and specialty distribution subsectors of the healthcare industry.